Distinguished in Breast Cancer

Dr. David A. Potter

Hematology Oncology | Surgical Oncology
Fairview Express Care
909 Fulton St Se, 
Minneapolis, MN 
Accepting New Patients
44 Years of Experience
Distinguished in Breast Cancer
Fairview Express Care
909 Fulton St Se, 
Minneapolis, MN 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

David Potter is a Hematologist Oncology specialist and a Surgical Oncologist in Minneapolis, Minnesota. Dr. Potter has been practicing medicine for over 44 years and is rated as a Distinguished provider by MediFind in the treatment of Breast Cancer. His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Inflammatory Breast Cancer. Dr. Potter is currently accepting new patients.

His clinical research consists of co-authoring 30 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 25 articles and participated in 2 clinical trials in the study of Breast Cancer.

Graduate Year
1982
Specialties
Hematology Oncology
Surgical Oncology
Licenses
Internal Medicine in IN
Hospital Affiliations
M Health Fairview University Of Mn
Fairview Lakes Health Services
M Health Fairview St John's Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
HealthPartners
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
Samaritan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE PART D
Sanford Health
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

FAIRVIEW EXPRESS CARE
909 Fulton St Se, Minneapolis, MN 55455
Other Locations
FAIRVIEW EXPRESS CARE
14500 99th Ave N, Suite 100, Maple Grove, MN 55369
FAIRVIEW EXPRESS CARE
5200 Fairview Blvd, Suite F, Wyoming, MN 55092
FAIRVIEW EXPRESS CARE
717 Delaware St Se, Suite 340, Minneapolis, MN 55414
FAIRVIEW EXPRESS CARE
500 Harvard St Se, Minneapolis, MN 55455

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Phase 2 Randomized, Double-Blinded, Controlled Study of Tucatinib vs Placebo in Combination With Capecitabine and Trastuzumab in Patients With Pretreated Unresectable Locally Advanced or Metastatic HER2+ Breast Carcinoma
Phase 2 Randomized, Double-Blinded, Controlled Study of Tucatinib vs Placebo in Combination With Capecitabine and Trastuzumab in Patients With Pretreated Unresectable Locally Advanced or Metastatic HER2+ Breast Carcinoma
Enrollment Status: Completed
Publish Date: August 14, 2023
Intervention Type: Drug
Study Drugs: tucatinib, capecitabine, trastuzumab
Study Phase: Phase 2
A Phase 1/2 Open-Label Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics and Efficacy of Seviteronel in Subjects With Advanced Breast Cancer
A Phase 1/2 Open-Label Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics and Efficacy of Seviteronel in Subjects With Advanced Breast Cancer
Enrollment Status: Completed
Publish Date: February 01, 2019
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
View 1 Less Clinical Trial

30 Total Publications

Cooling inflammation while potentiating immune checkpoint inhibition: Enhancing the benefit-risk ratio of immuno-oncology therapy.
Cooling inflammation while potentiating immune checkpoint inhibition: Enhancing the benefit-risk ratio of immuno-oncology therapy.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: February 14, 2024
Similar Doctors
Elite in Breast Cancer
Dr. Douglas K. Yee
Hematology Oncology | Hematology | Oncology
Elite in Breast Cancer
Dr. Douglas K. Yee
Hematology Oncology | Hematology | Oncology

Fairview Express Care

717 Delaware St Se, Suite 340, 
Minneapolis, MN 
 (0.2 miles away)
612-672-7422
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Douglas Yee is a Hematologist Oncology specialist and a Hematologist in Minneapolis, Minnesota. Dr. Yee is rated as a Distinguished provider by MediFind in the treatment of Breast Cancer. His top areas of expertise are Breast Cancer, Paget Disease of the Breast, HER-2 Positive Breast Cancer, and Angiosarcoma. Dr. Yee is currently accepting new patients.

Elite in Breast Cancer
Dr. Anne H. Blaes
Hematology Oncology | Hematology | Oncology
Elite in Breast Cancer
Dr. Anne H. Blaes
Hematology Oncology | Hematology | Oncology

Fairview Express Care

500 Harvard St Se, 
Minneapolis, MN 
 (0.3 miles away)
763-525-1746
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Anne Blaes is a Hematologist Oncology specialist and a Hematologist in Minneapolis, Minnesota. Dr. Blaes is rated as a Distinguished provider by MediFind in the treatment of Breast Cancer. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Colorectal Cancer, Adult Soft Tissue Sarcoma, and Bone Marrow Transplant. Dr. Blaes is currently accepting new patients.

Distinguished in Breast Cancer
Dr. Paul J. Zander
Hematology Oncology | Hematology | Oncology
Distinguished in Breast Cancer
Dr. Paul J. Zander
Hematology Oncology | Hematology | Oncology

Minnesota Oncology Hematology PA

910 E 26th St, Suite 100 200, 
Minneapolis, MN 
 (2.0 miles away)
612-884-6300
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Paul Zander is a Hematologist Oncology specialist and a Hematologist in Minneapolis, Minnesota. Dr. Zander is rated as a Distinguished provider by MediFind in the treatment of Breast Cancer. His top areas of expertise are Paget Disease of the Breast, Breast Cancer, Pleuropulmonary Blastoma, Lung Adenocarcinoma, and Bone Marrow Aspiration. Dr. Zander is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Potter's expertise for a condition
ConditionClose
    View All 23 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile